Special cell line collections curated for faster research

The special cell line collections from abm provide researchers with access to unique, well-characterised cellular models for studying complex biological processes, disease mechanisms, and therapeutic development. These specialised cell lines have been developed to support a wide range of applications, from immunology and inflammation research to metabolic disease, tissue regeneration, and hair biology.

By offering targeted collections that address specific research needs, abm helps scientists reduce development time and access relevant in vitro models that can improve experimental consistency and translational relevance. Whether investigating immune cell function, adipose tissue biology, skin physiology, or hair follicle development, these specialised collections provide reliable tools to accelerate discovery.

Mast cell lines

Mast cells are key regulators of immune responses and play critical roles in allergy, asthma, inflammation, and host defence. abm's mast cell line collection provides researchers with robust cellular models designed to support the investigation of mast cell activation, signalling pathways, mediator release, and immune system interactions.

These cell lines enable studies into allergic disease mechanisms, inflammatory responses, and the development of novel immunomodulatory therapies. Suitable for applications including cell signalling research, cytokine profiling, drug screening, and receptor function analysis, abm's mast cell models offer a valuable platform for advancing immunology research.

Applications:

• Allergy and hypersensitivity research
• Asthma and inflammatory disease studies
• Cytokine and mediator analysis
• Drug discovery and screening
• Immune signalling pathway investigations

Pre-adipocytes & dermal fibroblasts

The pre-adipocytes & dermal fibroblasts collection combines two important cell types widely used in metabolic, cosmetic, regenerative medicine, and skin biology research. Pre-adipocytes provide an essential model for studying adipogenesis, lipid metabolism, obesity, and metabolic disorders, while dermal fibroblasts play central roles in extracellular matrix production, wound healing, tissue repair, and skin ageing.

These cell models allow researchers to investigate the cellular and molecular mechanisms underlying adipose tissue development and skin physiology. They are particularly valuable for evaluating therapeutic candidates, cosmetic ingredients, and regenerative approaches aimed at improving skin health and metabolic function.

Applications:

• Adipogenesis and obesity research
• Metabolic disease studies
• Wound healing and tissue regeneration
• Skin ageing and cosmetic testing
• Extracellular matrix and fibrosis research

Dermal papilla collection

Dermal papilla cells are highly specialised mesenchymal cells located at the base of the hair follicle and are essential regulators of hair growth and follicle cycling. abm's dermal papilla collection provides researchers with relevant in vitro models for studying the biological pathways that govern hair follicle formation, maintenance, and regeneration.

These cells are widely used in hair biology research and support investigations into alopecia, follicle development, stem cell interactions, and potential hair restoration therapies. By enabling detailed analysis of signalling pathways involved in hair growth, dermal papilla cell models provide an important platform for both academic research and therapeutic development.

Applications:

• Hair growth and hair loss research
• Alopecia studies
• Hair follicle development and cycling
• Regenerative medicine and tissue engineering
• Hair restoration therapy development

Advance specialised cell research with abm

These special cell line collections offer researchers access to targeted cellular models designed to support a diverse range of scientific applications. From immune and inflammatory responses to skin biology, metabolism, and hair follicle research, these specialised collections provide dependable tools to help accelerate discovery and therapeutic innovation.